NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Reach Neuro, Inc.

Reach Neuro, Inc.

Private
Providence, Rhode IslandHealthcare & Life Scienceshttps://reachneuro.com/

Last Round

Angel

May 28, 2025

Total Funding Raised

$750,000

Company Overview

Reach Neuro, Inc. is a medical device company that develops implantable neuromodulation systems designed to restore upper-limb motor function in patients with chronic stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

neuromodulationspinal cord stimulationstroke rehabilitationimplantable medical deviceneurotechmotor function restorationupper limb paralysisbioelectronic medicineclinical programmingFDA breakthrough deviceneural interfacebrain computer interfaceBCI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Reach Neuro, Inc. Comparables

Compare Reach Neuro, Inc. with similar companies based on industry and business-model similarity.

Reach Neuro, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enspire DBS Therapy, Inc.
85%
Mobia Medical
78%
Vivani Medical
77%

Reach Neuro, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelMay 28, 2025
SeedJun 1, 2024
GrantApr 10, 2023
AcceleratorJan 1, 2022

Key People

Founding team and executive leadership

Douglas Weber

Chief Technology Officer

Executive Team

Reach Neuro, Inc. Investors

Notable investors and investment history

Reach Neuro, Inc. investors
InvestorRounds
NIH RADxGrant
Richard King Mellon FoundationSeed
IndieBioAccelerator
Angel Investor ForumAngel
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 28, 2025

    $125K raised from Angel Investor Forum.

Reach Neuro, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Reach Neuro, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Reach Neuro, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersProvidence, Rhode Island
Employee Range6
Year Founded2021
Last FundingMay 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.